OncoViews
Uniting oncologists for borderless exchange
Uniting healthcare professionals for
borderless exchange in oncology
CME-certified
All roundtable sessions accredited
UPCOMING
Join us forour roundtable in||latest advances in||your questions on||new therapies for||practice changes in||your patient cases in
Antibody Drug Conjugates
Giuseppe Banna
Portsmouth Hospitals NHS Trust, UK
Alessandra Curioni
Cantonal Hospital Fribourg, SWITZERLAND
Paolo Tarantino
Dana Farber Cancer Institute, USA
2 CME Points
SGMO • SSOM • SSMO
Join our host, Alessandra Curioni, for an insightful roundtable on the latest advancements in the treatment of lung, breast, and genitourinary cancers with antibody-drug conjugates (ADCs). This interdisciplinary event gathers renowned experts to discuss groundbreaking findings from the past year, offering an in-depth exploration of new innovative therapeutic approaches. Don’t miss this opportunity to enhance your understanding, engage in the discussion, and uncover the pivotal developments transforming the landscape of cancer treatment with ADCs.
ADD THIS TO YOUR CALENDAR
Google Calendar (Online)
Outlook Calendar (Open Downloaded File)-
Outlook On Microsoft Office 365 (Online) -
Outlook On The Web (Online) 
Apple Offline Calendar / iCal
When: 5:00 PM - 6:30 PM (CET)
Register here
Do You Have An Account Already?
No need to sign up again: as a verified OncoViewer, you will have access to all our upcoming sessions. Simply login to participate in this session.
First Time On OncoViews?
COMING SOON
- Google Calendar (Online)
- Outlook Calendar (Open Downloaded File)
- Outlook On Microsoft Office 365 (Online)
- Outlook On The Web (Online)
- Apple Offline Calendar / iCal
When: 15:00 - 17:30 (CET)
- Google Calendar (Online)
- Outlook Calendar (Open Downloaded File)
- Outlook On Microsoft Office 365 (Online)
- Outlook On The Web (Online)
- Apple Offline Calendar / iCal
When: 5:00 PM - 6:30 PM (CET)
- Google Calendar (Online)
- Outlook Calendar (Open Downloaded File)
- Outlook On Microsoft Office 365 (Online)
- Outlook On The Web (Online)
- Apple Offline Calendar / iCal
When: 5:00 PM - 6:30 PM (CET)
- Google Calendar (Online)
- Outlook Calendar (Open Downloaded File)
- Outlook On Microsoft Office 365 (Online)
- Outlook On The Web (Online)
- Apple Offline Calendar / iCal
When: 5:00 PM - 6:30 PM (CET)
LATEST
Roundtable Sessions
Coming Soon: Antibody Drug Conjugates
Gynecological Cancers
1 h 32 min
Chronic lymphocytic leukemia
1 h 30 min
Breast Cancer (ASCO 2024)
1 h 34 min
GI Cancers (ASCO 2024)
1 h 31 min
Lung Cancer (ASCO 2024)
1 h 32 min
GU Cancers (ASCO 2024)
1 h 36 min
DLBCL Debate: Bispecifics VS. CAR-T
1 h 32 min
HER2 in Lung, GYNE & GI Cancers
1 h 34 min
Prostate & Urothelial Cancer
1 h 32 min
Articles
FDA Approval
FDA Approvals Expand Treatment Options for Breast and Lung Cancers
PEAK Medicals
Bridging The Gap In Thoracic Oncology: What To Expect From The 6th ILCS
Jens Huober
HR+/HER2- Advanced Breast Cancer: Chemotherapy-Free Options For Various Subgroups
Konstantin Dedes
Early Breast Cancer: New Findings Through Subgroup And Biomarker Analyses
EMA Approval
European Commission Approves New Treatments for Urothelial and Lung Cancer
FDA Approval
FDA Approves New Treatments for Non-Small Cell Lung Cancer
Florian Lordick
HER2 As A Target For Gastrointestinal Tumors
FDA Approval
FDA Expands Cancer Treatment Options with New Drug Approvals
PEAK Medicals
Celebrating Breakthroughs in Lung Cancer Treatment on World Lung Cancer Day
EMA Approval
